Pancreatic cancer cells expressing the cell surface marker CD44+ CD24+ ESA+ phenotype had a 100-fold increased tumorigenic potential compared to non-tumorigenic cancer cells. The gene discussed is CD24; the disease is familial pancreatic carcinoma.